Latest Content

Testosterone Recovery in Prostate Cancer May Depend on ADT Intensity

October 23rd 2024, 3:00pm

By Ashley Chan

Patients with prostate cancer may differ in time to testosterone recovery, depending on the length of treatment and age, but takes six months on average.

An Oncology Nurse Who Goes Above and Beyond

October 23rd 2024, 1:00pm

By Dr. Sara Tolaney

Article

An oncology nurse from Dana-Farber Cancer Institute exudes the definition of an extraordinary healer, according to three colleagues.

Identifying Cardiovascular Disease Risk in Cancer Survivors

October 22nd 2024, 9:00pm

By Spencer Feldman

Article

The risk of cardiovascular disease is elevated in cancer survivors, regardless of treatment, and is influenced by cancer type and treatment-related factors.

Busting Palliative Care Misconceptions in Cancer Care

October 22nd 2024, 7:00pm

By Alex Biese

Article

Often mistaken as a synonym for hospice care, palliative care can be critical for patients with cancer and serious illnesses.

In Cancer, the Whole Is Greater Than the Sum of Its Parts

October 22nd 2024, 5:00pm

By Burt Rosen

Article

In addition to receiving my traditional cancer treatments, I also opt for integrative medicines, which have helped my mental health.

Treatment Side Effects, Quality of Life Factors in Prostate Cancer

October 22nd 2024, 3:00pm

By Ashley Chan

Article

It’s crucial for patients with prostate cancer to know that all treatments come with side effects, which may affect their quality of life.

FDA Approval of Trodelvy Withdrawn for Urothelial Carcinoma

October 22nd 2024, 1:00pm

By Darlene Dobkowski, MA

Article

The withdrawal of the FDA accelerated approval for locally advanced or metastatic urothelial carcinoma, a type of bladder cancer, does not affect other indications of the therapy.

Avutometinib and Defactinib May Benefit Some with Ovarian Cancer

October 21st 2024, 9:00pm

By Alex Biese

Article

Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.

Rise in PSA Levels May Predict Treatment Response in Prostate Cancer

October 21st 2024, 7:00pm

By Spencer Feldman

Article

The rate at which PSA rises after hormonal therapy for prostate cancer is a key factor in determining the effectiveness of the treatment.

My Unexplained Follicular Lymphoma-Related Weight Loss

October 21st 2024, 5:00pm

By Karen Cohn

Article

Whenever I get sick, I experience a few side effects that usually go away, but unexplained weight loss becomes a problem for me.

The Benefits of a Multidisciplinary Approach to Managing Prostate Cancer

October 21st 2024, 4:29pm

By Joseph F. Renzulli MD, FACS

Video

Panelists discuss how the landscape of treatment options for advanced prostate cancer has evolved, highlighting the importance of understanding current therapies to optimize patient outcomes.

Understanding Diagnosis and Partnering With Your Care Team

October 21st 2024, 4:29pm

By Joseph F. Renzulli MD, FACS

Video

Panelists discuss how sharing personal experiences with diagnosis helps illuminate the critical questions patients should ask their care teams and the pivotal role oncologists play in guiding treatment decisions.